AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 152 filers reported holding AKEBIA THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 1.76 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $13,000 | -59.4% | 5,454 | +128.7% | 0.00% | – |
Q2 2020 | $32,000 | +14.3% | 2,385 | -47.1% | 0.00% | – |
Q1 2020 | $28,000 | 0.0% | 4,506 | 0.0% | 0.00% | – |
Q4 2019 | $28,000 | +27.3% | 4,506 | -22.9% | 0.00% | – |
Q3 2019 | $22,000 | -24.1% | 5,847 | -5.8% | 0.00% | – |
Q2 2019 | $29,000 | -40.8% | 6,210 | 0.0% | 0.00% | – |
Q1 2019 | $49,000 | +104.2% | 6,210 | +37.8% | 0.00% | – |
Q4 2018 | $24,000 | – | 4,506 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alerce Investment Management, L.P. | 4,652,561 | $1,471,000 | 1.42% |
Orchard Capital Management, LLC | 251,826 | $80,000 | 0.03% |
GSA CAPITAL PARTNERS LLP | 486,568 | $154,000 | 0.02% |
Icon Wealth Advisors, LLC | 400,132 | $127 | 0.02% |
ACADIAN ASSET MANAGEMENT LLC | 7,483,053 | $2,365,000 | 0.01% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 2,042,816 | $646,000 | 0.01% |
WIPFLI FINANCIAL ADVISORS LLC, | 200,000 | $63,000 | 0.00% |
WEALTH EFFECTS LLC | 18,316 | $6,000 | 0.00% |
James J. Burns & Company, LLC | 25,142 | $8,000 | 0.00% |
Bayesian Capital Management, LP | 68,600 | $22,000 | 0.00% |